These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 3251045

  • 1. Production of C3 nephritic factor by cultured lymphocytes derived from a patient with partial lipodystrophy.
    Yamada A, Ohi H, Okano K, Watanabe S, Seki M, Hatano M, Koitabashi Y.
    J Clin Lab Immunol; 1988 Sep; 27(1):35-7. PubMed ID: 3251045
    [Abstract] [Full Text] [Related]

  • 2. [Production of C3 nephritic factor by cultured lymphocytes derived from glomerulonephritic patients].
    Yamada A, Ohi H, Hatano M.
    Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):373-8. PubMed ID: 2376910
    [Abstract] [Full Text] [Related]

  • 3. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M, Balow JE, Tsokos GC.
    J Immunol; 1986 Jun 15; 136(12):4451-5. PubMed ID: 3011894
    [Abstract] [Full Text] [Related]

  • 4. Familial incidence of C3 nephritic factor, partial lipodystrophy and membranoproliferative glomerulonephritis.
    Power DA, Ng YC, Simpson JG.
    Q J Med; 1990 Apr 15; 75(276):387-98. PubMed ID: 2385743
    [Abstract] [Full Text] [Related]

  • 5. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC, Peters DK.
    Clin Exp Immunol; 1986 Aug 15; 65(2):450-7. PubMed ID: 3641695
    [Abstract] [Full Text] [Related]

  • 6. [Effects of C3 nephritic factor on the complement system--with special reference to stabilizing effect on C3 convertase (C3bBb) activity (author's transl)].
    Nakanishi I.
    Nihon Jinzo Gakkai Shi; 1981 Jun 15; 23(6):719-32. PubMed ID: 6914399
    [No Abstract] [Full Text] [Related]

  • 7. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R, Lévy M, Gubler MC, Broyer M, Habib M.
    Arch Fr Pediatr; 1977 Jun 15; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [Abstract] [Full Text] [Related]

  • 8. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M, Sich M, Habib R.
    Arch Fr Pediatr; 1979 Nov 15; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
    Mollnes TE, Ng YC, Peters DK, Lea T, Tschopp J, Harboe M.
    Clin Exp Immunol; 1986 Jul 15; 65(1):73-9. PubMed ID: 3641694
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The role of carbohydrate in the structure and function of nephritic factor.
    Scott DM, Amos N, Bartolotti SR.
    Clin Exp Immunol; 1981 Oct 15; 46(1):120-9. PubMed ID: 6802534
    [Abstract] [Full Text] [Related]

  • 14. Herpes gestationis associated with the C3 nephritic factor.
    Grimwood R, Arroyave CM, Weston WL, Aeling JL.
    Arch Dermatol; 1980 Sep 15; 116(9):1045-7. PubMed ID: 6998378
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y, Ohi H, Watanabe S, Seki M, Hatano M.
    Clin Exp Immunol; 1989 Apr 15; 76(1):82-5. PubMed ID: 2736802
    [Abstract] [Full Text] [Related]

  • 17. Evidence that an autoantibody of IgG3 subclass against C3b discloses a C3 Nef activity in a pateint with partial lipodystrophy and glomerulonephritis.
    Fontaine M, Daveau M, Lebreton JP, Dumouchel L, Vannier JP, Godin M.
    Ann Immunol (Paris); 1980 Apr 15; 131C(1):39-53. PubMed ID: 6901590
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Mechanisms of action and clinical importance of C3-nephritic-factor (author's transl)].
    Lanzer G, Pogglitsch H, Tilz GP.
    Acta Med Austriaca; 1981 Apr 15; 8(1):7-13. PubMed ID: 6908995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.